Pro-Dex (NASDAQ:PDEX) Stock Passes Above 200-Day Moving Average – Should You Sell?

Shares of Pro-Dex, Inc. (NASDAQ:PDEX) passed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $54.80 and traded as high as $68.33. Pro-Dex shares last traded at $66.94, with a volume of 41,854 shares.

Wall Street Analyst Weigh In

Several research firms have recently commented on PDEX. Zacks Research raised shares of Pro-Dex to a “hold” rating in a research report on Tuesday, May 19th. Weiss Ratings raised Pro-Dex from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Thursday, August 6th. Wall Street Zen raised Pro-Dex from a “hold” rating to a “buy” rating in a research report on Saturday, June 13th. Finally, Ascendiant Capital Markets raised their target price on Pro-Dex from $56.00 to $70.00 and gave the company a “buy” rating in a research note on Tuesday, May 12th. Two analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. According to MarketBeat.com, Pro-Dex presently has a consensus rating of “Moderate Buy” and an average price target of $70.00.

Pro-Dex Price Performance

The firm has a 50-day moving average of $61.80 and a 200-day moving average of $55.06. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.14 and a current ratio of 3.67. The firm has a market capitalization of $209.49 million, a P/E ratio of 18.14 and a beta of 0.02.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Los Angeles Capital Management LLC bought a new stake in Pro-Dex in the 4th quarter worth approximately $37,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new position in shares of Pro-Dex during the 2nd quarter valued at $50,000. Bank of America Corp DE boosted its stake in shares of Pro-Dex by 173.3% in the 2nd quarter. Bank of America Corp DE now owns 1,692 shares of the medical instruments supplier’s stock worth $74,000 after buying an additional 1,073 shares during the last quarter. Wells Fargo & Company MN grew its holdings in shares of Pro-Dex by 65.4% in the fourth quarter. Wells Fargo & Company MN now owns 2,314 shares of the medical instruments supplier’s stock worth $89,000 after acquiring an additional 915 shares during the period. Finally, New York State Common Retirement Fund purchased a new stake in Pro-Dex during the second quarter valued at $105,000. Institutional investors own 15.28% of the company’s stock.

Pro-Dex Company Profile

Pro-Dex, Inc is a designer and manufacturer of precision drive systems and fluid management products serving the dental, medical, industrial and energy markets. The company specializes in high-speed, brushless micromotors and controllers, as well as pneumatic and fluid control devices, providing both standard and custom-engineered solutions for original equipment manufacturers.

Its product portfolio includes high-speed dental handpieces, turbine systems, rotary and reciprocating micro-drives, along with integrated fluid delivery systems.